New Zealand markets closed

Royalty Pharma plc (RPRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
37.50+0.11 (+0.29%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close37.39
Bid35.60 x 1100
Ask38.59 x 2200
Day's range37.11 - 37.60
52-week range34.80 - 53.23
Avg. volume2,338,767
Market cap22.769B
Beta (5Y monthly)N/A
PE ratio (TTM)30.36
EPS (TTM)1.24
Earnings date10 Nov 2021
Forward dividend & yield0.68 (1.82%)
Ex-dividend date18 Nov 2021
1y target est51.43
  • GlobeNewswire

    Royalty Pharma to Announce Third-Quarter 2021 Financial Results on November 10, 2021

    NEW YORK, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its third quarter of 2021 financial results on Wednesday, November 10, 2021 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 a.m. Eastern Time that day. Conference Call Information The conference call can be accessed live over the phone for U.S. callers by dialing (833) 519-1253 or for international callers by dialing +1

  • GlobeNewswire

    Royalty Pharma Declares Fourth-Quarter 2021 Dividend

    NEW YORK, Oct. 15, 2021 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the fourth quarter of 2021 of $0.17 per Class A ordinary share. The dividend will be paid on December 15, 2021, to shareholders of record at the close of business on November 19, 2021. About Royalty Pharma Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical

  • Simply Wall St.

    Shareholders in Royalty Pharma (NASDAQ:RPRX) are in the red if they invested a year ago

    The simplest way to benefit from a rising market is to buy an index fund. While individual stocks can be big winners...